%D8%A7%D8%B9%D8%AA%D9%84%D8%A7%D9%84_%D8%AF%D9%85%D8%A7%D8%BA%D9%8A_%D9%83%D8%A8%D8%AF%D9%8AEncefalopatia_hep%C3%A0ticaHepatisk_encefalopatiHepatische_EnzephalopathieHepatic_encephalopathyEncefalopat%C3%ADa_hep%C3%A1tica%D8%A7%D9%86%D8%B3%D9%81%D8%A7%D9%84%D9%88%D9%BE%D8%A7%D8%AA%DB%8C_%DA%A9%D8%A8%D8%AF%DB%8CHepaattinen_enkefalopatiaEnc%C3%A9phalopathie_h%C3%A9patique%D7%90%D7%A0%D7%A6%D7%A4%D7%9C%D7%95%D7%A4%D7%AA%D7%99%D7%94_%D7%9B%D7%91%D7%93%D7%99%D7%AA%D4%BC%D5%B5%D5%A1%D6%80%D5%A4%D5%A1%D5%B5%D5%AB%D5%B6_%D5%A7%D5%B6%D6%81%D5%A5%D6%86%D5%A1%D5%AC%D5%B8%D5%BA%D5%A1%D5%A9%D5%AB%D5%A1Encefalopatia_epatica%E8%82%9D%E6%80%A7%E8%84%B3%E7%97%87Hepatische_encefalopathie%E0%AC%B9%E0%AD%87%E0%AC%AA%E0%AC%BE%E0%AC%9F%E0%AC%BF%E0%AC%95_%E0%AC%8F%E0%AC%A8%E0%AC%B8%E0%AD%87%E0%AC%AB%E0%AC%BE%E0%AC%B2%E0%AD%8B%E0%AC%AA%E0%AC%BE%E0%AC%A5%E0%AC%BFEncefalopatia_w%C4%85trobowaEncefalopatia_hep%C3%A1tica%D0%9F%D0%B5%D1%87%D1%91%D0%BD%D0%BE%D1%87%D0%BD%D0%B0%D1%8F_%D0%BA%D0%BE%D0%BC%D0%B0Hepati%C4%8Dka_komaJetrna_encefalopatija%D0%A5%D0%B5%D0%BF%D0%B0%D1%82%D0%B8%D1%87%D0%BA%D0%B0_%D0%BA%D0%BE%D0%BC%D0%B0Leverkoma%E0%AE%95%E0%AE%B2%E0%AF%8D%E0%AE%B2%E0%AF%80%E0%AE%B0%E0%AE%B2%E0%AF%8D%E0%AE%A8%E0%AF%8B%E0%AE%AF%E0%AF%8D_%E0%AE%AE%E0%AF%82%E0%AE%B3%E0%AF%88%E0%AE%95%E0%AF%8D%E0%AE%95%E0%AF%8B%E0%AE%B3%E0%AE%BE%E0%AE%B1%E0%AF%81%E0%B0%B9%E0%B1%86%E0%B0%AA%E0%B0%BE%E0%B0%9F%E0%B0%BF%E0%B0%95%E0%B1%8D_%E0%B0%8E%E0%B0%A8%E0%B1%8D%E2%80%8C%E0%B0%B8%E0%B1%86%E0%B0%AB%E0%B0%B2%E0%B1%8B%E0%B0%AA%E0%B0%A4%E0%B0%BF%E0%B9%82%E0%B8%A3%E0%B8%84%E0%B8%AA%E0%B8%A1%E0%B8%AD%E0%B8%87%E0%B8%88%E0%B8%B2%E0%B8%81%E0%B8%95%E0%B8%B1%E0%B8%9A%D0%9F%D0%B5%D1%87%D1%96%D0%BD%D0%BA%D0%BE%D0%B2%D0%B0_%D0%B5%D0%BD%D1%86%D0%B5%D1%84%D0%B0%D0%BB%D0%BE%D0%BF%D0%B0%D1%82%D1%96%D1%8FB%E1%BB%87nh_n%C3%A3o_ganQ642548%E8%82%9D%E6%80%A7%E8%84%91%E7%97%85
about
To Assess Efficacy of Nutritional Therapy in Secondary Prophylaxis of Hepatic Encephalopathy Versus Lactulose in Patients With Liver Cirrhosis.Brain Energy Metabolism in Patients With Chronic Liver Disease and Impaired Central Nervous SystemEffect of Lactulose on Minimal Hepatic Encephalopathy and Health-Related Quality of LifeRICE Trial: Rifaximin In Chronic Hepatic Encephalopathy - A Randomized, Controlled TrialCerebrovascular Reactivity in Hepatic EncephalopathyComparison Between Erythromycin and Neomycin Treatment of Hepatic EncephalopathyStudy of Rifaximin in Minimal Hepatic EncephalopathyPhase 2B Efficacy/Safety of Ornithine Phenylacetate in Hospitalized Cirrhotic Patients With Hepatic Encephalopathy (STOP-HE)AST-120 Used to Treat Mild Hepatic EncephalopathyPharmacodynamics, Safety and Pharmacokinetics of the Oral Administration MNK6106 (L-ornithine Phenylacetate) vs Rifaximin in Participants With Hepatic Cirrhosis and a History of Prior Episodes of Hepatic EncephalopathyA Post-marketing Observational Study on Risk Factors for Hepatic Encephalopathy in Participants With Unresectable Hepatocellular CarcinomaRifaximin Soluble Solid Dispersion (SSD) Tablets Plus Lactulose for the Treatment of Overt Hepatic Encephalopathy (OHE)Efficacy of Combined Oral L-Ornithine-L-Aspartate and Lactulose in Patients With Hepatic EncephalopathyPost Transjugular Intrahepatic Portosystemic Shunt (Tips) Albumine Infusion to Prevent Hepatic EncephalopathyEffect of Tolvaptan on Cognitive Function in CirrhosisMonitoring of Encephalopathy in Cirrhotic Patients Admitted in Intensive CareS. Endotoxin, Inflammatory Mediators and MRS Before and After Treatment in MHEFecal Transplant for Hepatic EncephalopathyTo Compare Efficacy and Safety of Lactulose Versus Polyethylene Glycol for Treatment of Overt Hepatic Encephalopathy in Cirrhotics.Fecal Microbiota Transplant as Treatment of Hepatic EncephalopathyPhase II Study of Lactulose and Circadian Rhythms in Patients With CirrhosisMinimal Hepatic Encephalopathy in Hereditary Hemorrhagic TelangiectasianPlasma Free Amino Acids in Patients With Hepatic EncephalopathyEffect of Rifaximine on Sleep Disorders in Patients Suffering From Hepatic EncephalopathyFMT in Cirrhosis and Hepatic EncephalopathyEYE-Mobile TRACKer IN the Diagnosis of Minimal Hepatic EncephalopathyAcetyl-L-Carnitine In Severe Hepatic EncephalopathyOral Acetyl-L-Carnitine Therapy Reduces Fatigue In Hepatic EncephalopathyAcetyl-L-Carnitine Reduces Depression and Improves Quality of Life in Patients With Minimal Hepatic EncephalopathyRifaximin Plus Lactulose Versus Lactulose Alone for the Treatment of Hepatic Encephalopathy: a Double Blind Randomized TrialSecondary Prophylaxis of Hepatic Encephalopathy in CirrhosisCerebral Oxygen, Blood Flow and Ammonia Uptake in Patients With Cirrhosis and an Acute Episode of Hepatic Encephalopathy (HE)Primary Prophylaxis of Hepatic Encephalopathy in Patients With CirrhosisEffect of Lactose in Patients With Chronic Liver Disease and Minimal Hepatic EncephalopathySecondary Prophylaxis of Hepatic Encephalopathy With a Probiotic PreparationHyperproteic Diet Plus Lactobacillus Reuteri and Nitazoxanide in Minimal Hepatic EncephalopathyCerebrovascular Autoregulation During and After Liver TransplantationBioelectrical Impedance Vector Analysis in Cirrhotic PatientsSafety Study for Patients With a History of Hepatic EncephalopathyCoenzyme Q10 and Meclofenoxate in Hepatic Encephalopathy
P1050
P2175
P279
Evaluation and Management of Hepatic Encephalopathy: Current Status and Future DirectionsAssociation between proton pump inhibitors and hepatic encephalopathy: A meta-analysis.Hepatic encephalopathy.Radiographic imaging procedures in the diagnosis of the major central neuropathological consequences of alcohol abuse.Evidence of a vicious cycle in glutamine synthesis and breakdown in pathogenesis of hepatic encephalopathy-therapeutic perspectives.Hepatic encephalopathy--a serious complication of alcoholic liver disease.Hepatic encephalopathy: an updated approach from pathogenesis to treatmentA systematic review and meta-analysis of the use of oral zinc in the treatment of hepatic encephalopathy.How to diagnose and manage hepatic encephalopathy: a consensus statement on roles and responsibilities beyond the liver specialist.The GABA hypothesis of the pathogenesis of hepatic encephalopathy: current status.Contributions of microdialysis to new alternative therapeutics for hepatic encephalopathyAsymmetric Dimethylarginine and Hepatic Encephalopathy: Cause, Effect or Association?Prognostic assessment in patients with hepatic encephalopathy.Roles of changes in active glutamine transport in brain edema development during hepatic encephalopathy: an emerging conceptHepatic encephalopathy and sleepiness: an interesting connection?Hepatic encephalopathy: a critical current review.Current state of knowledge of hepatic encephalopathy (part III): non-absorbable disaccharides.Hyperammonemic coma after craniotomy: Hepatic encephalopathy from upper gastrointestinal hemorrhage or valproate side effect?: Case report and literature review.Alcohol's Effects on the Brain: Neuroimaging Results in Humans and Animal Models.Hepatic encephalopathy: Ever closer to its big bang.Update on the Therapeutic Management of Hepatic Encephalopathy.Quality of life in patients with minimal hepatic encephalopathyEffect of Lactulose on Minimal Hepatic Encephalopathy and Health-Related Quality of LifeCerebrovascular Reactivity in Hepatic EncephalopathyComparison Between Erythromycin and Neomycin Treatment of Hepatic EncephalopathyPhase 2B Efficacy/Safety of Ornithine Phenylacetate in Hospitalized Cirrhotic Patients With Hepatic Encephalopathy (STOP-HE)AST-120 Used to Treat Mild Hepatic EncephalopathyEfficacy of Combined Oral L-Ornithine-L-Aspartate and Lactulose in Patients With Hepatic EncephalopathyPost Transjugular Intrahepatic Portosystemic Shunt (Tips) Albumine Infusion to Prevent Hepatic EncephalopathyEffect of Tolvaptan on Cognitive Function in CirrhosisFMT in Cirrhosis and Hepatic EncephalopathySecondary Prophylaxis of Hepatic Encephalopathy in CirrhosisCerebral Oxygen, Blood Flow and Ammonia Uptake in Patients With Cirrhosis and an Acute Episode of Hepatic Encephalopathy (HE)Primary Prophylaxis of Hepatic Encephalopathy in Patients With CirrhosisEffect of Lactose in Patients With Chronic Liver Disease and Minimal Hepatic EncephalopathyTreatment of Hepatic Encephalopathy With Flumazenil and Change in Cortical GABA Levels in MRSGlutamine Challenge as Predictor of Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt (TIPS)Branched Chain Aminoacid Supplementation in Patients With Liver CirrhosisFructans, Lactitol and Lactose in Minimal Hepatic EncephalopathyRandomised Controlled Trial of Mechanistic Effects of Rifaximin in Cirrhosis and Chronic Hepatic Encephalopathy
P921
Q61909226-CA842755-1879-46D3-982E-161FAB24F7F2Q61921552-37FC3735-4580-42F6-B262-D7AFF84C3B7DQ61932344-AED9C7E6-383B-4277-8169-3B3C97838B5AQ61934458-BDF8FEEF-AC0D-401F-8137-670BC30CCE47Q61936228-EB077FDC-4165-44F6-9A24-54349A318425Q61936386-2FDB9DC2-C4B0-44E8-8FE1-5FA1B0F7E314Q61938962-AAF87074-6FA5-45F4-934C-F28B0BBC1CFFQ61975674-3775C692-1375-496A-9B98-564C4C7C5BF0Q61980874-9E3B1216-2371-46C7-B69E-6A49893F4284Q62041699-7B6A65DD-0CE9-4556-881D-5ABFB2DA2188Q62062177-C16D4913-72C7-44FD-BC14-F8BA3B79F625Q62818407-3A2272FF-D208-42E5-8172-3299755D60F2Q63062848-4288D847-29EA-47FC-883D-45BE9171D32CQ63316997-51703A0E-F35D-4E47-8DDD-0057ADED0659Q63318120-B8CDDD25-0D4B-4F36-A165-81AB4534B9FAQ63319790-1BB8948E-5A56-45A5-930A-7AF921FF4758Q63321505-A72E151A-3097-425B-B281-3A06CB39CECAQ63401152-14FB5D22-00B4-43DE-B4EE-68505B9675E9Q63401191-0F473DED-20B6-4ECF-8EAC-A5BCA88A2B4CQ63403323-DD5CC77F-7ABD-4D40-A6E0-8B2A4AAF6464Q63404473-ABC5C551-22A8-4B6B-BE99-1D73D7DD8472Q63571668-BD2E8A34-0393-4261-BAF0-7F154F39D1C0Q63573510-BDD4AAC7-F060-42EE-BF6A-9B00F79417CDQ63590713-A2B3E5F4-6193-40BC-A4A8-4B6E42958322Q63592577-BC996EFA-22A9-4040-A534-CA48EC4E1E1CQ63595720-772FF8AD-962F-4F24-B8DF-EB425BE8F27BQ63816954-9BDA7D2D-34EB-47EF-A01E-65CDDE07724DQ63817309-AD54E513-5866-40C6-9293-3D09F9BFE2BEQ63817311-97DE7173-A1A8-4722-97AC-180A29FC6EC4Q63818104-BFD025AD-06F9-4262-8C55-D16C55D1BE49Q63829437-8C5556FC-A931-4FC0-958B-829A3EDA17BCQ63829489-93C9D61F-560B-4DB8-9AD3-BA45B2655DF5Q63830137-D89BF08C-BBC0-4C9F-AAB4-73E8766756BFQ63832361-2D062D8D-A156-4002-AB5F-F86D48B5B6DBQ63833149-B97EEDC4-9A42-4E08-BC8D-95FEE4194964Q63833946-7B342AFE-62D2-487A-959F-2444B6D5E4C1Q63842268-6143E86B-CA5D-4934-9A25-3935B6EBA0C8Q63843506-E15CB0DF-320D-4D74-961F-DFB52697DAEDQ64045613-57F08C28-8DA5-4B5C-AE72-337CE9485F13Q64150926-1702A22F-2075-4986-AC6E-27EFC17284D9
P1050
description
Krankheit
@de
brain disease that is characte ...... o remove toxins from the blood
@en
condizione medica che si prese ...... usati da insufficienza epatica
@it
name
Bệnh não gan
@vi
Encefalopatia wątrobowa
@pl
Encefalopatía hepática
@es
Encéphalopathie hépatique
@fr
Hepaattinen enkefalopatia
@fi
Hepatische Enzephalopathie
@de
Hepatische encefalopathie
@nl
Hepatisk encefalopati
@da
Hepatička koma
@sh
Jetrna koma
@sl
type
label
Bệnh não gan
@vi
Encefalopatia wątrobowa
@pl
Encefalopatía hepática
@es
Encéphalopathie hépatique
@fr
Hepaattinen enkefalopatia
@fi
Hepatische Enzephalopathie
@de
Hepatische encefalopathie
@nl
Hepatisk encefalopati
@da
Hepatička koma
@sh
Jetrna koma
@sl
altLabel
Encefalopatia hepatica
@es
Portal-systemic encephalopathy
@en
coma epatico
@it
encefalopatia porto-sistemica
@it
hepatisk encefalopati
@nn
الغيبوبه الكبديه
@ar
غيبوبة كبدية
@ar
گیجی و خستگی کبدی
@fa
肝性腦病
@zh
prefLabel
Bệnh não gan
@vi
Encefalopatia wątrobowa
@pl
Encefalopatía hepática
@es
Encéphalopathie hépatique
@fr
Hepaattinen enkefalopatia
@fi
Hepatische Enzephalopathie
@de
Hepatische encefalopathie
@nl
Hepatisk encefalopati
@da
Hepatička koma
@sh
Jetrna koma
@sl
P1995
P672
P780
P828
P486
P508
P6366
P646
P1296
P1417
science/hepatic-encephalopathy
P1692
P1748
P2176
P2888
P2892
P31
P3417
Hepatic-Encephalopathy
P3827
hepatic-encephalopathy